OpenURL Connection Search

Select item for more details and to access through your institution.

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
Published in:
Hepatology Research, 2016, v. 46, n. 12, p. 1256, doi. 10.1111/hepr.12681
By:
- Morio, Kei;
- Imamura, Michio;
- Kawakami, Yoshiiku;
- Morio, Reona;
- Hatooka, Masahiro;
- Kan, Hiromi;
- Fujino, Hatsue;
- Fukuhara, Takayuki;
- Kobayashi, Tomoki;
- Masaki, Keiichi;
- Ono, Atsushi;
- Nakahara, Takashi;
- Urabe, Ayako;
- Yokoyama, Satoe;
- Nagaoki, Yuko;
- Kawaoka, Tomokazu;
- Hiraga, Nobuhiko;
- Tsuge, Masataka;
- Hiramatsu, Akira;
- Hayes, C Nelson
Publication type:
Article
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.
Published in:
Hepatology Research, 2014, v. 44, n. 14, p. E447, doi. 10.1111/hepr.12336
By:
- Nagaoki, Yuko;
- Imamura, Michio;
- Kawakami, Yoshiiku;
- Kan, Hiromi;
- Fujino, Hatsue;
- Fukuhara, Takayuki;
- Kobayashi, Tomoki;
- Ono, Atsushi;
- Nakahara, Takashi;
- Naeshiro, Noriaki;
- Urabe, Ayako;
- Yokoyama, Satoe;
- Miyaki, Daisuke;
- Murakami, Eisuke;
- Kawaoka, Tomokazu;
- Tsuge, Masataka;
- Hiramatsu, Akira;
- Aikata, Hiroshi;
- Takahashi, Shoichi;
- Hayes, C. Nelson
Publication type:
Article
Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients.
Published in:
Hepatology Research, 2014, v. 44, n. 3, p. 280, doi. 10.1111/hepr.12129
By:
- Takaki, Shintaro;
- Kawakami, Yoshiiku;
- Miyaki, Daisuke;
- Nakahara, Takashi;
- Naeshiro, Noriaki;
- Murakami, Eisuke;
- Tanaka, Mio;
- Honda, Yohji;
- Yokoyama, Satoe;
- Nagaoki, Yuko;
- Kawaoka, Tomokazu;
- Hiramatsu, Akira;
- Tsuge, Masataka;
- Hiraga, Nobuhiko;
- Imamura, Michio;
- Hyogo, Hideyuki;
- Aikata, Hiroshi;
- Takahashi, Shoichi;
- Arihiro, Koji;
- Chayama, Kazuaki
Publication type:
Article
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.
Published in:
2017
By:
- Morio, Reona;
- Imamura, Michio;
- Kawakami, Yoshiiku;
- Morio, Kei;
- Kobayashi, Tomoki;
- Yokoyama, Satoe;
- Kimura, Yuki;
- Nagaoki, Yuko;
- Kawaoka, Tomokazu;
- Tsuge, Masataka;
- Hiramatsu, Akira;
- Nelson Hayes, C.;
- Aikata, Hiroshi;
- Takahashi, Shoichi;
- Miki, Daiki;
- Ochi, Hidenori;
- Mori, Nami;
- Takaki, Shintaro;
- Tsuji, Keiji;
- Chayama, Kazuaki
Publication type:
journal article
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.
Published in:
Journal of Gastroenterology, 2014, v. 49, n. 12, p. 1548, doi. 10.1007/s00535-013-0924-9
By:
- Fujino, Hatsue;
- Imamura, Michio;
- Nagaoki, Yuko;
- Kawakami, Yoshiiku;
- Abe, Hiromi;
- Hayes, C.;
- Kan, Hiromi;
- Fukuhara, Takayuki;
- Kobayashi, Tomoki;
- Masaki, Keiichi;
- Ono, Atsushi;
- Nakahara, Takashi;
- Honda, Youji;
- Naeshiro, Noriaki;
- Urabe, Ayako;
- Yokoyama, Satoe;
- Miyaki, Daisuke;
- Murakami, Eisuke;
- Kawaoka, Tomokazu;
- Hiraga, Nobuhiko
Publication type:
Article
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.
Published in:
Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 3, p. 645, doi. 10.1111/jgh.13511
By:
- Morio, Kei;
- Imamura, Michio;
- Kawakami, Yoshiiku;
- Morio, Reona;
- Kobayashi, Tomoki;
- Yokoyama, Satoe;
- Nagaoki, Yuko;
- Kawaoka, Tomokazu;
- Tsuge, Masataka;
- Hiramatsu, Akira;
- Makokha, Grace Naswa;
- Hayes, C Nelson;
- Aikata, Hiroshi;
- Miki, Daiki;
- Ochi, Hidenori;
- Honda, Yoji;
- Mori, Nami;
- Takaki, Shintaro;
- Tsuji, Keiji;
- Chayama, Kazuaki
Publication type:
Article
Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score-matched analysis.
Published in:
Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 2, p. 337, doi. 10.1111/jgh.12706
By:
- Yokoyama, Satoe;
- Kawakami, Yoshiiku;
- Imamura, Michio;
- Hayes, C Nelson;
- Kohno, Hiroshi;
- Kohno, Hirotaka;
- Tsuji, Keiji;
- Aisaka, Yasuyuki;
- Kira, Shinsuke;
- Yamashina, Keitarou;
- Nonaka, Michihiro;
- Takahashi, Shoichi;
- Moriya, Takashi;
- Kitamoto, Mikiya;
- Aimitsu, Shiomi;
- Nakanishi, Toshio;
- Kawakami, Hiroiku;
- Chayama, Kazuaki
Publication type:
Article

Found: 7

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C.

Non-invasive liver fibrosis score calculated by combination of virtual touch tissue quantification and serum liver functional tests in chronic hepatitis C patients.

Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.

Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score-matched analysis.